Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor secondary prophylaxis in capecitabine combined with oxaliplatin (CapeOX) regimen in the treatment of colorectal cancer

ABSTRACT: Interventions: Experimental group:The test drug PEG-rhG-CSF injection was administered 24-48 hours after the end of oxaliplatin intravenous infusion Primary outcome(s): The incidence of 2-4 grade neutropenia during the treatment period Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2739432 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR